Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00199_DB06335_nanopub.RA45mEQbsMgU3jsO4D4V6aRohUf2w9NfVxVJXaselP61k#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00199_DB06335 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00199_DB06335 label "DDI between Erythromycin and Saxagliptin - Erythromycin is an inhibitor of CYP3A4 which increases exposure of saxagliptin. Decrease dose of saxagliptin to 2.5 mg per day. [drugbank_resource:DB00199_DB06335]" assertion.
- drugbank_resource:DB00199_DB06335 identifier "drugbank_resource:DB00199_DB06335" assertion.
- drugbank_resource:DB00199_DB06335 title "DDI between Erythromycin and Saxagliptin - Erythromycin is an inhibitor of CYP3A4 which increases exposure of saxagliptin. Decrease dose of saxagliptin to 2.5 mg per day." assertion.
- drugbank:DB00199 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB06335 assertion.
- drugbank:DB06335 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB06335 assertion.